Zhengye Biotechnology Holding (ZYBT) Long-Term Deferred Tax (2023 - 2025)

Zhengye Biotechnology Holding has reported Long-Term Deferred Tax over the past 3 years, most recently at $14663.2 for Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 99.04% to $14663.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14663.2 through Dec 2025, down 99.04% year-over-year, with the annual reading at $15000.0 for FY2025, 99.0% down from the prior year.
  • Long-Term Deferred Tax was $14663.2 for Q4 2025 at Zhengye Biotechnology Holding, down from $2.3 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $2.3 million in Q2 2025 and troughed at $14663.2 in Q4 2025.
  • The 3-year median for Long-Term Deferred Tax is $1.6 million (2023), against an average of $1.4 million.
  • Year-over-year, Long-Term Deferred Tax dropped 7.53% in 2024 and then tumbled 99.04% in 2025.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $1.7 million in 2023, then fell by 7.53% to $1.5 million in 2024, then tumbled by 99.04% to $14663.2 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Long-Term Deferred Tax are $14663.2 (Q4 2025), $2.3 million (Q2 2025), and $1.5 million (Q4 2024).